Seasonal distribution of antiphospholipid antibodies

Stroke

Volumn 32, Issue 8, 2001, Pages 1707-1711

  Luong, Thanh Ha ^a   Rand, Jacob H ^a   Wu, Xiao Xuan ^a   Godbold, James H ^a   Gascon Lema, Mayra ^a   Tuhrim, Stanley ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Antibodies, anticardiolipin; Antibodies, antiphospholipid; Phosphatidyl serines; Seasons; Stroke

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEASONAL VARIATION; STROKE; THROMBOSIS;

EID: 0034894078     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.32.8.1707     Document Type: Article

References (30)

1. Antiphospholipid antibodies: A critique of their heterogeneity and hegemony
2. Antiphospholipid antibodies: Basic immunology and assays
3. The anticardiolipin syndrome
4. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders
5. Antiphospholipid antibody syndrome: New insights on thrombogenic mechanism
6. The antiphospholipid syndrome: Diagnosis, management, and pathogenesis
7. Anticardiolipin response and its association with infections in young and middle-aged patients with cerebral infarction
8. Anticardiolipin response in acute infections
9. Profile of autoantibodies in the serum of patients with tuberculosis, klebsiella and other Gram-negative infections
10. Induction of anticardiolipin antibody and/or lupus anticoagulani in rabbits by immunization with lipoteichoic acid, lipopolysaccharide and lipid A
11. The minorities risk factors and stroke study (MRFASS)
12. A test for seasonality of events with a variable population at risk
13. Antiphosphatidyl serine antibodies are independently associated with ischemic stroke
14. An elevated anticardiolipin antibody titer is a stroke risk factor or degree of positivity
15. The lupus anticoagulant/antiphospholipid syndrome
16. Immunology and clinical importance of antiphospholipid antibodies
17. Natural autoantibodies in the serum of healthy women: A five-year follow-up
18. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects
19. Antiphospholipid and thrombosis syndrome
20. Anticardiolipin antibodies in Lyme disease
21. Circulating coagulation inhibitors in the acquired immunodeficiency syndrome
22. Antiphospholipid antibodies and Mycoplasma pneumoniae infection
23. Effective inhibition of cardiolipin-binding antibodies in Gram-negative infections by bacterial lipopolysaccharide
24. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: Beta 2-glycoprotein I (apolipoprotein H)
25. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor
26. Anticardiolipin antibodies and binding of anionic phospholipids and serum proteins
27. Lupus anticoagulant antibodies: Recognition of phospholipid binding protein complex
28. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: An explanation for their pathogenic mechanism?
29. A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection
30. Etiology and epidemiology